Search clinical trials for: Infliximab

Total 418 results

The Alfred
Merck Sharp & Dohme LLC

Unknown

Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum

Inflammatory Bowel Diseases
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)

Arthritis, Psoriatic
HaEmek Medical Center, Israel
Bnai Zion Medical Center; Carmel Medical Center

Withdrawn

Intraarticular Injection of Infliximab

Arthritis

Israel
Centocor Ortho Biotech Services, L.L.C.

Completed

PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Psoriasis
Centocor, Inc.
Centocor BV

Completed

A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

Ankylosing Spondylitis
Merck Sharp & Dohme LLC

Completed

Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352) (CANDLE)

Spondylitis, Ankylosing
Icahn School of Medicine at Mount Sinai

Withdrawn

Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema

Uveitic Macular Edema | Intraocular Inflammation

United States
Professor Robert Sutton
Merck Sharp & Dohme LLC; Medical Research Council; Liverpool University Hospitals... and other collaborators

Recruiting

Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind Multi-centre Trial (RAPID-I) (RAPID-I)

Acute Pancreatitis

United Kingdom
Hikma Pharmaceuticals LLC
Syneos Health

Completed

Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan (PASSRRA)

Rheumatoid Arthritis

Jordan
Centocor Ortho Biotech Services, L.L.C.

Completed

The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol

Arthritis, Rheumatoid
Jonsson Comprehensive Cancer Center
American Cancer Society, Inc.

Terminated

Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer

Breast Cancer | Fatigue

United States
University Hospital, Tours
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Infliximab and Methotrexate in Ankylosing Spondylitis (SPAXIM)

Ankylosing Spondylitis

France
Icahn School of Medicine at Mount Sinai

Unknown

Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema

Diabetic Macular Edema

United States
Asan Medical Center
Samsung Medical Center; Seoul National University Hospital; Kyungpook National... and other collaborators

Recruiting

Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD (CHAMELEON)

Crohn's Disease

Korea, Republic of
Chinese University of Hong Kong

Completed

Combination Methotrexate and Infliximab

Ankylosing Spondylitis
Centocor, Inc.

Completed

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

Crohn Disease
Centre hospitalier de l'Université de Montréal...
Fonds de recherche en ophtalmologie de l'Université de Montréal

Recruiting

Topical Infliximab for Sterile Corneal Melt

Sterile Corneal Melt

Canada
University of California, San Francisco

Completed

Early Serum Infliximab Levels in Severe Ulcerative Colitis. (EaSiFx)

Inflammatory Bowel Disease | Ulcerative Colitis (UC)

United States
Hospital Universitario Marqués de Valdecilla
Schering-Plough

Unknown

Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica

Polymyalgia Rheumatica

Spain
Centocor Ortho Biotech Services, L.L.C.
Schering-Plough

Completed

Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC

Crohn Disease

United States, France, United Kingdom, Germany, Spain, Belgium, Israel, Greece, Canada, Netherlands, Austria, Norway, Denmark, Sweden, Portugal
University Hospital, Ghent
Abbott

Completed

Switching From Adalimumab to Infliximab (ADA-IFX)

Crohn's Disease

Belgium
Merck Sharp & Dohme LLC

Completed

Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)

Arthritis, Rheumatoid
Janssen Inc.

Completed

The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy (ICE)

Crohn's Disease

Canada
University of Alberta
Juvenile Diabetes Research Foundation

Completed

Islet Transplantation Using Campath-1H and Infliximab Induction

Type 1 Diabetes

Canada
Oslo University Hospital
Vestre Viken Hospital Trust; University Hospital of North Norway; Diakonhjemmet... and other collaborators

Completed

BackToBasic: Infliximab in Chronic Low Back Pain and Modic Changes

Low Back Pain

Norway
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Ulcerative Colitis

Poland
Rennes University Hospital

Recruiting

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis (EFFICACI)

Ulcerative Colitis

France
Cairo University

Completed

Intravitreal Infliximab for Proliferative Vitreoretinopathy (FIXER)

Rhegmatogenous Retinal Detachment | Retinal Detachment | Proliferative Vitreoretinopathy

Egypt
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)

Crohn's Disease

France, Turkey, Czechia, Greece, Latvia, Hungary, Belarus, Israel, United States, Spain, Bulgaria, Serbia, Croatia, Italy, Germany, India, Japan, Mexico, Moldova, Republic of, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa and more
Children's Memorial Health Institute, Poland

Unknown

Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease

Crohn Disease

Poland
University of Iowa

Completed

Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD

Graft vs Host Disease

United States
Regionshospitalet Viborg, Skive

Completed

Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease
University Hospital Schleswig-Holstein

Completed

Clinical and Molecular Phenotyping in IBD (Phen_IBD)

IBD

Germany
Janssen Biotech, Inc.

Active, not recruiting

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease (DEVELOP)

Inflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis | Indeterminate Colitis

United States, Canada
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Celltrion

Active, not recruiting

A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC (PEREM)

Inflammatory Bowel Diseases

France
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD

Crohn Disease

China
Centocor, Inc.

Completed

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease

Crohn Disease
University of Western Ontario, Canada
Prometheus Laboratories

Terminated

Evaluation of Health Costs and Resource Utilization (Test-NoTest)

Crohn's Disease | Ulcerative Colitis

United States
KU Leuven

Completed

Effect of Anti TNFa Upon Deep Endometriosis Associated Pain (Infliximab)

Endometriosis

Belgium
Centocor, Inc.

Completed

Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis
Chiba University

Completed

Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis (OPTIWIT)

Arthritis, Rheumatoid

Japan
Second Affiliated Hospital of Wenzhou Medical University

Completed

Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease

Crohn Disease

China
National Eye Institute (NEI)

Completed

Infliximab to Treat Non-Infectious Scleritis

Scleritis

United States
Karolinska Institutet
Medical Research Council; Schering-Plough

Completed

Treatment With TNF Blockade, Infliximab, in Patients With Myositis

Refractory Myositis
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Anorexia | Fatigue | Lung Cancer | Cachexia

United States
Zhang, Xiao, M.D.
Xijing Hospital; Tianjin Medical University General Hospital; Central South University

Unknown

Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients (INNOVATION)

Rheumatoid Arthritis（RA）

China
Charite University, Berlin, Germany
dfg

Unknown

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Reactive Arthritis

Germany
Schneider Children's Medical Center, Israel

Terminated

Infliximab Accelerated Induction in Moderate to Severe Pediatric UC (INDUCE)

Ulcerative Colitis

Israel
Janssen Korea, Ltd., Korea

Completed

A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease (BEGIN)

Behcet Disease

Korea, Republic of
Hvidovre University Hospital

Completed

Regulatory T-cells and Crohn's Disease (CrohnReg)

Crohn Disease

Denmark

Search clinical trials for: Infliximab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations